Michael Erman
Michael Erman
I write for Reuters. My articles can be found here: http://blogs.reuters.com/michael-erman/Source
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
2 reviews

RECENT ARTICLES

Sort by:
No Rating
U.S. parents begin to ask: Should my child get a COVID-19 shot?

U.S. parents begin to ask: Should my child get a COVID-19 shot?

Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.The Sweeten children, Kaden, Jackson and Emily, are seen at their home in Layton, Utah, U.S., November 8, 2020. Picture taken November 8, 2020. Tristen Sweeten/Handout via REUTERS Tristen Sweeten, a 34-year-old nurse in Utah, hopes her three children will receive Moderna’s COVID-19 vaccine through its pediatric clinical trial. The sooner the better, she said, for their safety and the greater goal of ending the pandemic.Angie Ankoma, a 45-year-old Black mother of four who works in...

Apr 16
Worthy
Share
Save
Give Tip
Review
No Rating
Johnson & Johnson COVID-19 vaccine backed by advisory panel, U.S. authorization to follow

Johnson & Johnson COVID-19 vaccine backed by advisory panel, U.S. authorization to follow

By , (Reuters) - A panel of expert advisers to the U.S. Food and Drug Administration on Friday voted to recommend authorization of Johnson & Johnson’s one-dose COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout.The FDA is likely to authorize the vaccine for emergency use within a day or so, making it the third available in the United States, and the only one that requires a single shot.The panel consisting of doctors, infectious disease experts and medical researchers voted unanimously that the benefits of the vaccine outweigh its risks in people age...

Feb 26
Worthy
Share
Save
Give Tip
Review
No Rating
Pfizer says South African variant could significantly reduce protective antibodies

Pfizer says South African variant could significantly reduce protective antibodies

By (This February 17 story corrects headline and first paragraph to show the reduction was in the protective antibodies elicited by the vaccine, not the protection of the vaccine overall)Slideshow (Reuters) - A laboratory study suggests that the South African variant of the coronavirus may reduce protective antibodies elicited by the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.The study found the vaccine was still able to neutralize the virus and there is not yet evidence from trials in...

Feb 17
Worthy
Share
Save
Give Tip
Review
No Rating
Pfizer says South African variant could significantly reduce protective antibodies

Pfizer says South African variant could significantly reduce protective antibodies

By (This February 17 story corrects headline and first paragraph to show the reduction was in the protective antibodies elicited by the vaccine, not the protection of the vaccine overall)Slideshow (Reuters) - A laboratory study suggests that the South African variant of the coronavirus may reduce protective antibodies elicited by the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.The study found the vaccine was still able to neutralize the virus and there is not yet evidence from trials in...

Feb 17
Worthy
Share
Save
Give Tip
Review
No Rating
Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk

Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk

By , NEW YORK (Reuters) - Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.The hikes come as drugmakers are reeling from effects of the COVID-19 pandemic, which has reduced doctor visits and demand for some drugs. They are also fighting new drug price cutting rules from the Trump administration, which would reduce the industry’s profitability.The companies kept their price increases at 10% or below, and the...

+1
Dec 31
Worthy
Share
Save
Give Tip
Review
No Rating
U.S. investigating 5 allergic reactions to Pfizer coronavirus vaccine - National | Globalnews.ca

U.S. investigating 5 allergic reactions to Pfizer coronavirus vaccine - National | Globalnews.ca

Want to discuss? Please read our first.AdvertisementClose XAAThe U.S. Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE’s vaccine in the United States this week, a top FDA official said late on Friday.Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said at a press conference that the allergic reactions had been reported in more than one state, including in Alaska.Marks also said that a chemical called polyethylene glycol (PEG) that is an ingredient in the...

Dec 19
Worthy
Share
Save
Give Tip
Review
No Rating
We can stop COVID-19: Moderna vaccine success gives world more hope

We can stop COVID-19: Moderna vaccine success gives world more hope

By , The vaccines, both developed with new technology known as messenger RNA (mRNA), represent powerful tools to fight a pandemic that has infected 54 million people worldwide and killed 1.3 million.Unlike Pfizer’s vaccine, Moderna’s shot can be stored at normal fridge temperatures, which should make it easier to distribute, a critical factor as COVID-19 cases are soaring, hitting new records in the United States and pushing some European countries back into lockdowns.“We are going to have a vaccine that can stop COVID-19,” Moderna President Stephen Hoge said in a telephone...

+1
Nov 16
Worthy
Share
Save
Give Tip
Review
No Rating
'Great day for humanity': Pfizer says COVID-19 vaccine over 90% effective

'Great day for humanity': Pfizer says COVID-19 vaccine over 90% effective

By , Health experts said Pfizer’s results were positive for all COVID-19 vaccines currently in development since they show the shots are going after the right target and are a proof of concept that the disease can be halted with vaccination.“Today is a great day for science and humanity,” Albert Bourla, Pfizer’s chairman and chief executive, said.“We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.”If Pfizer’s vaccine is...

+1
Nov 9
Worthy
Share
Save
Give Tip
Review
No Rating
Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern

Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern

By , Lilly said earlier this month it was applying for emergency use authorization (EUA) for the antibody drug, LY-CoV555, for patients with mild to moderate COVID-19 based on data from another clinical trial.It is not uncommon to pause drug trials to investigate safety concerns, and such actions do not necessarily indicate a serious problem. Because of the urgent need for drugs and vaccines to tackle a pandemic that has claimed over 1 million lives worldwide - and the speed with which they are being developed - these trials have come under intense scrutiny.“Out of an abundance of caution,...

+1
October 13, 2020
Worthy
Share
Save
Give Tip
Review
No Rating
Trump signs U.S. healthcare executive orders that may have little impact

Trump signs U.S. healthcare executive orders that may have little impact

By , , CHARLOTTE, N.C. (Reuters) - U.S. President Donald Trump on Thursday signed two executive orders on healthcare for Americans that lawyers said will carry little weight, as the president seeks to boost his flagging credibility with voters on the hot-button issue ahead of the Nov. 3 presidential election.Trump signed the twin orders implementing his “America First Healthcare Plan” in an airport hangar in Charlotte, North Carolina, amid an audience that included medical professionals.“Under my plan 33 million Medicare beneficiaries will soon receive a card in the mail containing $200...

+1
September 24, 2020
Worthy
Share
Save
Give Tip
Review
  • Total 11 items
  • 1
  • 2
OUTLETS
reuters.com

reuters.com

CRITIC
img-trusted
100%
PUBLIC
img-trusted
75%
yahoo.com

yahoo.com

CRITIC
img-trusted
94%
PUBLIC
img-trusted
78%
globalnews.ca

globalnews.ca

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A